The Victorian Government and La Trobe University jointly establish the Artificial Intelligence Medical Innovation Center to promote global AI medical research.

The Victorian Government and La Trobe University jointly establish the Artificial Intelligence Medical Innovation Center to promote global AI medical research.

La Trobe University

La Trobe University
Click the blue text above to follow La Trobe University

A

C

A

M

I

On September 6, 2024, the Treasurer of the Victorian Government of Australia presided over the launch ceremony and held a press conference, announcingAustralian Centre for Artificial Intelligence in Medical Innovation(Australian Centre for Artificial Intelligence in Medical Innovation) officially launched. This is not only Australia's first AI medical research center, but alsothe world's first center focused on accelerating personalized cancer vaccine innovation research through AI + Nobel Prize mRNA technology.

World's First AI Medical Research Center

Victorian Government Investment10 million AUDand La Trobe University jointly established ACAMI, a world-class research center, with La Trobe University also investing9.3 million AUD.Victorian Treasurer Tim Pallassaid: 'Our investment in ACAMI will help Victorian researchers achieve major medical breakthroughs and save more lives.'

Victorian Treasurer Tim Pallas

Internationally renowned scholar, Cisco Chair Professor of Artificial Intelligence, Director of the Cisco-La Trobe AI IoT Research CenterProfessor Xiang Wei, was jointly appointed by the Victorian Government and La Trobe University asACAMI Founding Director and Chief Scientist.

ACAMI Founding Director and Chief Scientist - Professor Xiang Wei

AI and Nobel Prize mRNA Technology Combine to Drive Medical Innovation

The combination of AI and mRNA technology was the driving force behind the rapid rollout of global COVID-19 vaccines. The 2023 Nobel Prize in Medicine was awarded to two outstanding scientists who invented mRNA vaccine technology, Katalin Karikó and Drew Weissman. Professor Katalin Karikó has long served as Senior Vice President of BioNTech.


The Victorian Government andGerman Nobel Prize-winning biotech giant BioNTechare collaborating to build the largest mRNA vaccine manufacturing center in the Southern Hemisphere at La Trobe University's Melbourne campus. ACAMI will further advance AI medical research through close collaboration with BioNTech.

NVIDIA Supercomputing Accelerates Research

NVIDIA also announced that it will provide the Australian Centre for Artificial Intelligence in Medical Innovation ACAMI withAustralia's first NVIDIA DGX H200 supercomputerand the NVIDIA Clara platform to accelerate AI medical diagnostics and research.


Rory Kelleher, NVIDIA's Global Head of Healthcare and Life Sciences, stated: 'AI and accelerated computing can address major challenges in the healthcare industry. ACAMI's AI projects will bring tangible benefits to patients in disease detection and treatment planning.'

AI-Driven Victorian Healthcare Ecosystem

ACAMI is located in La Trobe University's Research and Innovation Park, becoming part of the 'Future University City'. Through collaboration with the Victorian Government, ACAMI will play a key role in building Victoria's AI-driven healthcare ecosystem, ensuring the state's world-leading medical technology keeps pace with global AI capabilities.


La Trobe University President Professor Theo Farrell said: 'Collaborating with the Victorian Government to establish ACAMI is not only significant for scientific discovery but also provides students with valuable learning opportunities.'

La Trobe University President Professor Theo Farrell

Professor Xiang Wei explained that AI technology will also significantly shorten drug development time, promoting the discovery of new therapies and clinical trials. 'Through AI technology, we can develop precise personalized medical solutions tailored to each patient's unique genetic characteristics, which will greatly improve treatment outcomes.'


Professor Xiang Wei also pointed out: 'In the foreseeable future, we will use AI technology to achieve personalized customization of various cancer vaccines. AI and mRNA technology bring us closer to this goal.'

Initial Project Development: Digital Twin and Cancer Research

ACAMI has launched several initial projects, one of which is collaborating withthe Olivia Newton-John Cancer Research Instituteto develop a 'digital twin' of breast cancer tumors.


This virtual model can predict patients' responses to immunotherapy, potential side effects, and survival rates. This marks the first application of 'digital twin' technology in supporting clinical decision-making, signifying its successful transition from NASA's aerospace applications to the medical field.

Scan the QR code to try creating your 'digital twin' (please open on PC)

Professor Nilmini Wickramasinghe, Optus Chair in Digital Health at La Trobe University, said: 'The natural evolution of AI technology is towards healthcare, as patients increasingly demand personalized, precise cancer treatments. The role of AI in healthcare is comparable to the revolutionary impact of antibiotics on medicine.'

Scan the QR code to learn more about ACAMI projects

Broad Prospects for AI Industry Employment

According to data from Invest Victoria, Victoria accounts for nearly60% of Australia's pharmaceutical exports, making it the state's highest-value advanced manufacturing export product.The establishment of ACAMI will further consolidate Victoria's leadership in global medical innovation.


Additionally, the biotechnology industry employs over100,000people in Victoria. According to the Australian Technology Council, employment in the AI industry has increased from 800 in 2014 to 33,000 in 2023, and is expected to create200,000 jobs by 2030.La Trobe University will cultivate more professionals for this rapidly growing industry through the Australian Centre for Artificial Intelligence in Medical Innovation.

La Trobe University Master's Programs

Unlock Your Career Future

La Trobe University's IT, AI, and Digital Health master's programs offer students multiple internship opportunities, helping them succeed in the fields of artificial intelligence and medical technology. We also boastVictoria's number one employer satisfaction*, making us the top choice for student employment. Join La Trobe and become the next driver of global AI medical innovation!

*Quality Indicators for Learning and Teaching (QILT), 2023, 2022

Click the 'Read Original' below for details

Disclaimer: The information contained in this article is for reference only. While we strive to provide complete and accurate information at the time of publication, the university does not guarantee its accuracy, timeliness, or completeness. The university reserves the right to change content at its sole discretion at any time, including but not limited to changing admission or assessment requirements, or changing or discontinuing any course or subject. To the extent permitted by law, the university is not liable for any loss or damage arising from the use of any information in this article. For updated course information, please visit: latrobe.edu.au/courses

La Trobe University is a registered provider under the Commonwealth Register of Institutions and Courses for Overseas Students (CRICOS). La Trobe University CRICOS Provider Code 00115M TEQSA PRV12132 - Australian University May 2024

English Official Website

Chinese Official Website

Remember to keep following La Trobe University's official WeChat,

to get the latest information on related courses, employment support, scholarships, and more!

Contact Us!

La Trobe China Regional Admissions Officer LTUGlobal@latrobe.edu.au
Follow La Trobe University Australia
We are waiting for you in Australia
Whats App